| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 35 | 2024 | 345 | 7.300 |
Why?
|
| Islets of Langerhans | 84 | 2020 | 544 | 6.960 |
Why?
|
| Insulin | 82 | 2023 | 1160 | 5.440 |
Why?
|
| Insulin-Secreting Cells | 35 | 2021 | 397 | 5.350 |
Why?
|
| Familial Primary Pulmonary Hypertension | 29 | 2024 | 60 | 4.530 |
Why?
|
| Proinsulin | 42 | 2020 | 124 | 4.500 |
Why?
|
| Glucose | 63 | 2020 | 638 | 4.140 |
Why?
|
| Conservation of Natural Resources | 6 | 2023 | 79 | 2.140 |
Why?
|
| Animals | 205 | 2024 | 26581 | 2.020 |
Why?
|
| Agriculture | 4 | 2017 | 38 | 1.990 |
Why?
|
| Rats | 88 | 2024 | 3990 | 1.860 |
Why?
|
| Environmental Restoration and Remediation | 4 | 2015 | 6 | 1.730 |
Why?
|
| Obesity | 18 | 2023 | 963 | 1.690 |
Why?
|
| Antioxidants | 9 | 2023 | 223 | 1.670 |
Why?
|
| SOXF Transcription Factors | 7 | 2023 | 9 | 1.630 |
Why?
|
| Diabetes Mellitus, Type 2 | 23 | 2023 | 1373 | 1.610 |
Why?
|
| Phosphoproteins | 16 | 2020 | 254 | 1.560 |
Why?
|
| Hydrogen | 4 | 2016 | 47 | 1.490 |
Why?
|
| Eating | 13 | 2021 | 166 | 1.480 |
Why?
|
| Food Supply | 4 | 2017 | 28 | 1.450 |
Why?
|
| Signal Transduction | 47 | 2020 | 3241 | 1.440 |
Why?
|
| Insulin Receptor Substrate Proteins | 16 | 2011 | 55 | 1.410 |
Why?
|
| Copper | 4 | 2023 | 71 | 1.350 |
Why?
|
| Humans | 158 | 2024 | 86601 | 1.260 |
Why?
|
| Protein Precursors | 12 | 2007 | 143 | 1.240 |
Why?
|
| Environmental Pollution | 3 | 2018 | 13 | 1.180 |
Why?
|
| Electron Spin Resonance Spectroscopy | 7 | 2017 | 306 | 1.150 |
Why?
|
| Mice | 81 | 2024 | 11352 | 1.140 |
Why?
|
| Communicable Diseases | 5 | 2009 | 63 | 1.120 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 7 | 2023 | 14 | 1.100 |
Why?
|
| Receptors, Leptin | 13 | 2020 | 32 | 1.090 |
Why?
|
| Green Chemistry Technology | 3 | 2015 | 3 | 1.080 |
Why?
|
| Insulin-Like Growth Factor I | 13 | 2010 | 114 | 1.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2017 | 567 | 1.030 |
Why?
|
| Climate Change | 5 | 2023 | 42 | 1.020 |
Why?
|
| Free Radicals | 10 | 2017 | 73 | 1.020 |
Why?
|
| Hypothalamus | 8 | 2021 | 79 | 1.020 |
Why?
|
| Proteome | 5 | 2022 | 124 | 1.020 |
Why?
|
| Soil | 3 | 2014 | 31 | 0.990 |
Why?
|
| Biomarkers | 16 | 2023 | 1718 | 0.990 |
Why?
|
| Apoptosis | 16 | 2021 | 1683 | 0.990 |
Why?
|
| Exocytosis | 15 | 2020 | 108 | 0.980 |
Why?
|
| Gene Expression Regulation | 21 | 2020 | 1920 | 0.970 |
Why?
|
| Hyperglycemia | 11 | 2020 | 176 | 0.960 |
Why?
|
| Leptin | 12 | 2021 | 105 | 0.940 |
Why?
|
| Insecticides | 3 | 2018 | 27 | 0.930 |
Why?
|
| Male | 98 | 2023 | 40956 | 0.930 |
Why?
|
| Follistatin | 1 | 2023 | 7 | 0.930 |
Why?
|
| Protein Biosynthesis | 7 | 2007 | 378 | 0.920 |
Why?
|
| Renewable Energy | 2 | 2015 | 4 | 0.920 |
Why?
|
| Carbon Dioxide | 3 | 2016 | 188 | 0.920 |
Why?
|
| Neurons | 17 | 2021 | 1546 | 0.890 |
Why?
|
| Ecosystem | 4 | 2021 | 316 | 0.890 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 8 | 0.880 |
Why?
|
| Disease Outbreaks | 5 | 2009 | 154 | 0.870 |
Why?
|
| Models, Statistical | 6 | 2014 | 574 | 0.870 |
Why?
|
| Petroleum | 3 | 2013 | 13 | 0.870 |
Why?
|
| Metabolomics | 4 | 2021 | 68 | 0.850 |
Why?
|
| Carbon Cycle | 2 | 2012 | 7 | 0.840 |
Why?
|
| Receptor, Insulin | 6 | 2013 | 54 | 0.830 |
Why?
|
| Models, Chemical | 3 | 2013 | 178 | 0.820 |
Why?
|
| Cytoplasmic Granules | 13 | 2002 | 94 | 0.810 |
Why?
|
| Proto-Oncogene Proteins | 12 | 2005 | 645 | 0.790 |
Why?
|
| Pulmonary Embolism | 2 | 2021 | 221 | 0.780 |
Why?
|
| Gasoline | 2 | 2012 | 3 | 0.770 |
Why?
|
| Cell Line | 32 | 2020 | 2468 | 0.760 |
Why?
|
| RNA, Messenger | 23 | 2017 | 1981 | 0.750 |
Why?
|
| Peptide Fragments | 12 | 2023 | 460 | 0.750 |
Why?
|
| Human Genetics | 1 | 2020 | 6 | 0.740 |
Why?
|
| HLA-DP beta-Chains | 2 | 2021 | 8 | 0.740 |
Why?
|
| Models, Biological | 11 | 2012 | 1749 | 0.730 |
Why?
|
| Insulin Resistance | 12 | 2023 | 377 | 0.730 |
Why?
|
| Endothelium, Vascular | 7 | 2016 | 435 | 0.730 |
Why?
|
| Environmental Pollutants | 2 | 2018 | 51 | 0.720 |
Why?
|
| Brain | 3 | 2022 | 2216 | 0.720 |
Why?
|
| Solitary Nucleus | 5 | 2021 | 21 | 0.720 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2018 | 318 | 0.700 |
Why?
|
| Biofuels | 2 | 2016 | 10 | 0.690 |
Why?
|
| Protein Processing, Post-Translational | 18 | 2020 | 371 | 0.690 |
Why?
|
| Endopeptidases | 10 | 1995 | 116 | 0.690 |
Why?
|
| HLA-DP alpha-Chains | 1 | 2018 | 6 | 0.690 |
Why?
|
| Insecta | 1 | 2019 | 48 | 0.680 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 7 | 2021 | 35 | 0.680 |
Why?
|
| Plastics | 1 | 2018 | 7 | 0.670 |
Why?
|
| Blood Glucose | 12 | 2021 | 873 | 0.670 |
Why?
|
| Rats, Sprague-Dawley | 27 | 2019 | 1219 | 0.660 |
Why?
|
| Environmental Policy | 1 | 2018 | 2 | 0.660 |
Why?
|
| Rats, Wistar | 13 | 2018 | 297 | 0.660 |
Why?
|
| Pollination | 1 | 2018 | 8 | 0.650 |
Why?
|
| Mesons | 3 | 2012 | 9 | 0.650 |
Why?
|
| Bees | 1 | 2018 | 11 | 0.650 |
Why?
|
| Extinction, Biological | 1 | 2019 | 85 | 0.650 |
Why?
|
| Energy Metabolism | 8 | 2021 | 271 | 0.650 |
Why?
|
| Endangered Species | 1 | 2018 | 23 | 0.650 |
Why?
|
| Cell Division | 13 | 2005 | 696 | 0.650 |
Why?
|
| Biodiversity | 2 | 2023 | 197 | 0.650 |
Why?
|
| DNA Damage | 6 | 2023 | 366 | 0.640 |
Why?
|
| Blood Proteins | 2 | 2022 | 144 | 0.640 |
Why?
|
| Reactive Oxygen Species | 9 | 2023 | 480 | 0.640 |
Why?
|
| Cells, Cultured | 29 | 2021 | 2818 | 0.640 |
Why?
|
| Glucagon-Like Peptide 1 | 8 | 2021 | 48 | 0.630 |
Why?
|
| Starvation | 1 | 2018 | 23 | 0.630 |
Why?
|
| Fasting | 3 | 2018 | 161 | 0.630 |
Why?
|
| Secretory Vesicles | 8 | 2020 | 43 | 0.630 |
Why?
|
| Feedback, Physiological | 2 | 2011 | 62 | 0.630 |
Why?
|
| Enzyme Activation | 18 | 2012 | 692 | 0.630 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2016 | 19 | 0.590 |
Why?
|
| Cell Plasticity | 2 | 2017 | 8 | 0.580 |
Why?
|
| RNA | 3 | 2020 | 560 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 21 | 2021 | 3092 | 0.580 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2010 | 74 | 0.580 |
Why?
|
| Vascular Remodeling | 4 | 2020 | 21 | 0.570 |
Why?
|
| Iron | 4 | 2022 | 164 | 0.570 |
Why?
|
| MicroRNAs | 4 | 2021 | 534 | 0.560 |
Why?
|
| Nanotechnology | 2 | 2014 | 68 | 0.550 |
Why?
|
| Nuclear Power Plants | 2 | 2013 | 2 | 0.550 |
Why?
|
| Phosphatidylinositol 3-Kinases | 16 | 2010 | 262 | 0.540 |
Why?
|
| Water | 3 | 2016 | 275 | 0.540 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 13 | 2011 | 379 | 0.530 |
Why?
|
| Peptides | 7 | 2020 | 639 | 0.530 |
Why?
|
| Bioelectric Energy Sources | 2 | 2012 | 2 | 0.520 |
Why?
|
| Regeneration | 2 | 2007 | 143 | 0.520 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 217 | 0.520 |
Why?
|
| Interleukin-6 | 8 | 2024 | 256 | 0.520 |
Why?
|
| RNA, Transfer | 1 | 2016 | 151 | 0.520 |
Why?
|
| Energy-Generating Resources | 2 | 2012 | 3 | 0.510 |
Why?
|
| Oxidative Stress | 10 | 2021 | 447 | 0.510 |
Why?
|
| Lipoproteins, HDL | 3 | 2021 | 96 | 0.510 |
Why?
|
| Female | 45 | 2022 | 44507 | 0.500 |
Why?
|
| Carrier Proteins | 7 | 2012 | 673 | 0.500 |
Why?
|
| Fatty Acids, Nonesterified | 4 | 2003 | 70 | 0.500 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2024 | 126 | 0.500 |
Why?
|
| NFATC Transcription Factors | 2 | 2011 | 29 | 0.500 |
Why?
|
| Fukushima Nuclear Accident | 1 | 2014 | 1 | 0.490 |
Why?
|
| Food Industry | 1 | 2014 | 2 | 0.490 |
Why?
|
| Nuclear Reactors | 1 | 2014 | 8 | 0.490 |
Why?
|
| Middle Aged | 25 | 2022 | 25017 | 0.490 |
Why?
|
| Pulmonary Artery | 8 | 2023 | 305 | 0.490 |
Why?
|
| Mice, Knockout | 20 | 2021 | 1924 | 0.480 |
Why?
|
| Calcium | 10 | 2022 | 1156 | 0.480 |
Why?
|
| Internationality | 1 | 2014 | 69 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinases | 10 | 2009 | 222 | 0.470 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2019 | 123 | 0.470 |
Why?
|
| Phosphorylation | 16 | 2013 | 1106 | 0.470 |
Why?
|
| Radioisotopes | 2 | 2012 | 45 | 0.470 |
Why?
|
| Oxygen | 4 | 2016 | 726 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2023 | 2270 | 0.460 |
Why?
|
| Thorium | 1 | 2013 | 1 | 0.460 |
Why?
|
| rab3A GTP-Binding Protein | 3 | 2007 | 4 | 0.460 |
Why?
|
| Endothelial Cells | 7 | 2024 | 428 | 0.450 |
Why?
|
| Mining | 1 | 2013 | 3 | 0.450 |
Why?
|
| Soil Pollutants | 1 | 2013 | 7 | 0.450 |
Why?
|
| Fatty Acids | 3 | 2010 | 130 | 0.450 |
Why?
|
| Biodegradation, Environmental | 1 | 2013 | 17 | 0.450 |
Why?
|
| Adult | 25 | 2022 | 25640 | 0.450 |
Why?
|
| Calcium Signaling | 2 | 2011 | 129 | 0.450 |
Why?
|
| Photochemistry | 1 | 2013 | 38 | 0.450 |
Why?
|
| Mice, Transgenic | 16 | 2022 | 1540 | 0.450 |
Why?
|
| Glucagon | 7 | 2018 | 111 | 0.450 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 212 | 0.450 |
Why?
|
| Forkhead Transcription Factors | 3 | 2011 | 166 | 0.440 |
Why?
|
| Islet Amyloid Polypeptide | 2 | 2012 | 25 | 0.440 |
Why?
|
| Cattle | 5 | 2012 | 376 | 0.440 |
Why?
|
| Diet, High-Fat | 5 | 2023 | 114 | 0.440 |
Why?
|
| Genetic Therapy | 7 | 2020 | 342 | 0.440 |
Why?
|
| Phosphorus | 1 | 2013 | 118 | 0.440 |
Why?
|
| Environmental Exposure | 2 | 2019 | 296 | 0.440 |
Why?
|
| Lithium | 2 | 2012 | 59 | 0.440 |
Why?
|
| Hyperinsulinism | 3 | 2023 | 51 | 0.440 |
Why?
|
| Pediatric Obesity | 2 | 2023 | 22 | 0.430 |
Why?
|
| Hypothalamic Area, Lateral | 4 | 2016 | 11 | 0.430 |
Why?
|
| Foot-and-Mouth Disease | 1 | 2012 | 1 | 0.430 |
Why?
|
| Pancreas | 4 | 2017 | 239 | 0.430 |
Why?
|
| Protein Kinase C | 8 | 2005 | 270 | 0.430 |
Why?
|
| Nuclear Fusion | 1 | 2012 | 1 | 0.430 |
Why?
|
| Solar Energy | 1 | 2012 | 1 | 0.430 |
Why?
|
| Charcoal | 1 | 2012 | 13 | 0.420 |
Why?
|
| Electric Power Supplies | 1 | 2012 | 9 | 0.420 |
Why?
|
| Oxidation-Reduction | 6 | 2023 | 373 | 0.420 |
Why?
|
| Mitochondria | 6 | 2020 | 535 | 0.420 |
Why?
|
| Viral Vaccines | 1 | 2012 | 43 | 0.410 |
Why?
|
| Calcineurin | 1 | 2011 | 16 | 0.410 |
Why?
|
| Insulinoma | 10 | 2012 | 37 | 0.410 |
Why?
|
| Models, Immunological | 1 | 2012 | 80 | 0.410 |
Why?
|
| Antigens, Viral | 1 | 2012 | 143 | 0.410 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 13 | 0.410 |
Why?
|
| Autoantigens | 1 | 2012 | 127 | 0.410 |
Why?
|
| Hepatocytes | 2 | 2011 | 127 | 0.410 |
Why?
|
| Water Pollutants, Chemical | 1 | 2013 | 135 | 0.400 |
Why?
|
| Receptors, Calcitonin | 3 | 2021 | 4 | 0.400 |
Why?
|
| Disease Models, Animal | 12 | 2023 | 2232 | 0.400 |
Why?
|
| Cyclic GMP | 3 | 2014 | 58 | 0.390 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 1384 | 0.390 |
Why?
|
| Adenoviridae | 14 | 2019 | 345 | 0.390 |
Why?
|
| Vascular Diseases | 2 | 2023 | 119 | 0.390 |
Why?
|
| Epithelial Cells | 3 | 2018 | 669 | 0.390 |
Why?
|
| Transfection | 16 | 2017 | 896 | 0.390 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2023 | 56 | 0.390 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 4 | 2016 | 16 | 0.380 |
Why?
|
| DNA | 12 | 2023 | 1294 | 0.380 |
Why?
|
| Air Pollutants | 1 | 2012 | 78 | 0.380 |
Why?
|
| Phytoplankton | 1 | 2010 | 7 | 0.380 |
Why?
|
| Ecology | 1 | 2011 | 74 | 0.380 |
Why?
|
| Proteoglycans | 6 | 1995 | 121 | 0.380 |
Why?
|
| Global Warming | 1 | 2010 | 6 | 0.380 |
Why?
|
| Subtilisins | 6 | 1996 | 27 | 0.380 |
Why?
|
| Influenza, Human | 2 | 2010 | 329 | 0.370 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.370 |
Why?
|
| Neoplasms | 5 | 2020 | 2897 | 0.370 |
Why?
|
| Zeolites | 1 | 2010 | 4 | 0.370 |
Why?
|
| Prognosis | 7 | 2023 | 3674 | 0.370 |
Why?
|
| Erythrocytes | 1 | 2011 | 255 | 0.370 |
Why?
|
| Venoms | 2 | 2006 | 12 | 0.360 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 102 | 0.360 |
Why?
|
| Cell Survival | 6 | 2005 | 969 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 10 | 2013 | 937 | 0.350 |
Why?
|
| Models, Molecular | 3 | 2018 | 1286 | 0.350 |
Why?
|
| Membrane Proteins | 10 | 2020 | 1196 | 0.350 |
Why?
|
| Metals | 2 | 2023 | 90 | 0.350 |
Why?
|
| Biomedical Research | 3 | 2022 | 375 | 0.350 |
Why?
|
| Cohort Studies | 5 | 2022 | 2767 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 7 | 2010 | 68 | 0.340 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2010 | 100 | 0.340 |
Why?
|
| Transcription, Genetic | 14 | 2012 | 1135 | 0.340 |
Why?
|
| Eukaryota | 1 | 2009 | 44 | 0.330 |
Why?
|
| Body Weight | 9 | 2023 | 459 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-akt | 11 | 2009 | 322 | 0.330 |
Why?
|
| Hypertension | 1 | 2017 | 1141 | 0.330 |
Why?
|
| Transcription Factors | 5 | 2023 | 1565 | 0.320 |
Why?
|
| Isoenzymes | 6 | 2011 | 271 | 0.320 |
Why?
|
| Autoimmunity | 2 | 2022 | 160 | 0.320 |
Why?
|
| Growth Differentiation Factor 15 | 3 | 2013 | 9 | 0.320 |
Why?
|
| Diabetes Mellitus, Experimental | 6 | 2021 | 190 | 0.320 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1578 | 0.320 |
Why?
|
| Proteomics | 5 | 2022 | 212 | 0.320 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 827 | 0.310 |
Why?
|
| Transcriptome | 4 | 2021 | 580 | 0.310 |
Why?
|
| Vagus Nerve | 3 | 2021 | 45 | 0.310 |
Why?
|
| Drug Discovery | 1 | 2008 | 103 | 0.310 |
Why?
|
| Polyamines | 3 | 2023 | 32 | 0.300 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2011 | 63 | 0.300 |
Why?
|
| Liver | 6 | 2020 | 1229 | 0.300 |
Why?
|
| 5' Untranslated Regions | 1 | 2007 | 49 | 0.300 |
Why?
|
| Vaccination | 3 | 2012 | 254 | 0.300 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 80 | 0.300 |
Why?
|
| Inflammation | 7 | 2023 | 920 | 0.290 |
Why?
|
| Carbon | 2 | 2010 | 80 | 0.290 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 159 | 0.290 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2016 | 302 | 0.290 |
Why?
|
| Pediculus | 2 | 2016 | 3 | 0.290 |
Why?
|
| Diuretics | 1 | 2007 | 124 | 0.290 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 1620 | 0.280 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 134 | 0.280 |
Why?
|
| Measles | 3 | 2008 | 15 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 579 | 0.280 |
Why?
|
| Aspartic Acid Endopeptidases | 3 | 1996 | 66 | 0.280 |
Why?
|
| Protein Binding | 6 | 2023 | 1456 | 0.280 |
Why?
|
| Kinetics | 12 | 2004 | 1513 | 0.280 |
Why?
|
| Fibroblasts | 5 | 2020 | 729 | 0.270 |
Why?
|
| Computer Simulation | 4 | 2012 | 1078 | 0.270 |
Why?
|
| Biological Evolution | 2 | 2010 | 918 | 0.270 |
Why?
|
| Prosencephalon | 2 | 2022 | 62 | 0.270 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2017 | 137 | 0.270 |
Why?
|
| Hypoxia | 5 | 2024 | 641 | 0.260 |
Why?
|
| Chronic Disease | 3 | 2021 | 970 | 0.260 |
Why?
|
| Aged | 14 | 2022 | 18402 | 0.260 |
Why?
|
| MAP Kinase Signaling System | 3 | 2020 | 192 | 0.260 |
Why?
|
| Palmitic Acid | 5 | 2014 | 26 | 0.260 |
Why?
|
| Lung | 4 | 2023 | 1170 | 0.260 |
Why?
|
| Amyloid | 4 | 2012 | 85 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2024 | 2356 | 0.260 |
Why?
|
| Pro-Opiomelanocortin | 4 | 2018 | 12 | 0.260 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 301 | 0.260 |
Why?
|
| Machine Learning | 3 | 2022 | 232 | 0.260 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2017 | 166 | 0.250 |
Why?
|
| Peptide YY | 2 | 2021 | 9 | 0.250 |
Why?
|
| Methane | 1 | 2004 | 10 | 0.250 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2024 | 43 | 0.250 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 456 | 0.250 |
Why?
|
| Survival Analysis | 3 | 2019 | 1538 | 0.250 |
Why?
|
| Receptors, Cell Surface | 5 | 2014 | 286 | 0.250 |
Why?
|
| Cathepsin Z | 1 | 2024 | 1 | 0.240 |
Why?
|
| Endarterectomy | 2 | 2021 | 20 | 0.240 |
Why?
|
| Time Factors | 12 | 2020 | 5209 | 0.240 |
Why?
|
| Proteins | 7 | 2006 | 777 | 0.240 |
Why?
|
| Mitogens | 2 | 2003 | 64 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2017 | 1961 | 0.240 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 246 | 0.240 |
Why?
|
| Protein Transport | 5 | 2020 | 411 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 165 | 0.230 |
Why?
|
| Flavonoids | 2 | 2023 | 85 | 0.230 |
Why?
|
| Hydroxyl Radical | 1 | 2023 | 35 | 0.230 |
Why?
|
| Ascorbic Acid | 1 | 2023 | 37 | 0.230 |
Why?
|
| Population Density | 2 | 2008 | 60 | 0.230 |
Why?
|
| Computational Biology | 2 | 2021 | 528 | 0.230 |
Why?
|
| Inhibins | 1 | 2023 | 37 | 0.230 |
Why?
|
| Young Adult | 7 | 2020 | 5974 | 0.230 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2023 | 3 | 0.230 |
Why?
|
| Autophagy | 3 | 2012 | 149 | 0.230 |
Why?
|
| Gene Expression | 8 | 2021 | 1284 | 0.230 |
Why?
|
| Seawater | 1 | 2023 | 43 | 0.230 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 44 | 0.230 |
Why?
|
| Activins | 1 | 2023 | 26 | 0.230 |
Why?
|
| Environmental Monitoring | 2 | 2014 | 71 | 0.230 |
Why?
|
| Tissue Culture Techniques | 3 | 2011 | 79 | 0.230 |
Why?
|
| Calcium-Binding Proteins | 3 | 2019 | 115 | 0.220 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2023 | 148 | 0.220 |
Why?
|
| Molecular Sequence Data | 17 | 2014 | 3030 | 0.220 |
Why?
|
| Metalloproteins | 1 | 2022 | 16 | 0.220 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 102 | 0.220 |
Why?
|
| Succinates | 1 | 2002 | 21 | 0.220 |
Why?
|
| Manganese | 1 | 2022 | 53 | 0.220 |
Why?
|
| Base Sequence | 14 | 2020 | 2330 | 0.220 |
Why?
|
| Cytokines | 4 | 2023 | 776 | 0.220 |
Why?
|
| Benzaldehydes | 1 | 2002 | 4 | 0.220 |
Why?
|
| Toluene | 1 | 2002 | 5 | 0.220 |
Why?
|
| Benzene | 1 | 2002 | 8 | 0.220 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2001 | 225 | 0.220 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2022 | 23 | 0.210 |
Why?
|
| Ventral Tegmental Area | 3 | 2011 | 43 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2012 | 316 | 0.210 |
Why?
|
| Immunohistochemistry | 7 | 2018 | 1753 | 0.210 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2001 | 10 | 0.210 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 96 | 0.210 |
Why?
|
| Power Plants | 2 | 2012 | 5 | 0.210 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2002 | 50 | 0.210 |
Why?
|
| Membrane Transport Proteins | 2 | 2018 | 166 | 0.210 |
Why?
|
| Free Radical Scavengers | 2 | 2017 | 59 | 0.210 |
Why?
|
| Biomass | 2 | 2012 | 32 | 0.210 |
Why?
|
| Luteolin | 1 | 2021 | 4 | 0.210 |
Why?
|
| Growth Differentiation Factor 2 | 2 | 2020 | 152 | 0.210 |
Why?
|
| Diabetes Mellitus | 4 | 2014 | 806 | 0.210 |
Why?
|
| Case-Control Studies | 7 | 2020 | 1804 | 0.210 |
Why?
|
| Calmodulin | 2 | 2001 | 50 | 0.210 |
Why?
|
| Prolactin-Releasing Hormone | 1 | 2021 | 1 | 0.210 |
Why?
|
| Adenosine Triphosphate | 4 | 2002 | 314 | 0.210 |
Why?
|
| Epidermal Growth Factor | 1 | 2002 | 119 | 0.210 |
Why?
|
| Glycerol Kinase | 1 | 2001 | 1 | 0.210 |
Why?
|
| Epidemics | 2 | 2013 | 33 | 0.210 |
Why?
|
| Microscopy, Fluorescence | 4 | 2020 | 425 | 0.210 |
Why?
|
| Glyburide | 4 | 2006 | 32 | 0.210 |
Why?
|
| Elafin | 1 | 2021 | 2 | 0.210 |
Why?
|
| Neuropeptides | 3 | 2011 | 112 | 0.200 |
Why?
|
| Gastric Bypass | 2 | 2021 | 110 | 0.200 |
Why?
|
| Leukocyte Elastase | 1 | 2021 | 8 | 0.200 |
Why?
|
| Neural Stem Cells | 1 | 2022 | 58 | 0.200 |
Why?
|
| Circulating MicroRNA | 1 | 2021 | 12 | 0.200 |
Why?
|
| Thermodynamics | 3 | 2012 | 309 | 0.200 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 21 | 0.200 |
Why?
|
| Untranslated Regions | 1 | 2001 | 19 | 0.200 |
Why?
|
| Area Under Curve | 1 | 2022 | 334 | 0.200 |
Why?
|
| Plasmids | 2 | 2021 | 287 | 0.200 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2011 | 48 | 0.200 |
Why?
|
| Proprotein Convertase 9 | 1 | 2021 | 20 | 0.200 |
Why?
|
| Amino Acid Sequence | 12 | 2017 | 2062 | 0.200 |
Why?
|
| Kaempferols | 1 | 2021 | 3 | 0.200 |
Why?
|
| Receptor, IGF Type 1 | 4 | 2008 | 44 | 0.200 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2021 | 19 | 0.200 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 70 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2022 | 132 | 0.200 |
Why?
|
| Cell Count | 3 | 2013 | 195 | 0.200 |
Why?
|
| Education | 1 | 2021 | 58 | 0.200 |
Why?
|
| Risk Factors | 5 | 2024 | 5416 | 0.200 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 113 | 0.200 |
Why?
|
| Spermine | 1 | 2020 | 18 | 0.190 |
Why?
|
| Glycogen Synthase | 1 | 2020 | 22 | 0.190 |
Why?
|
| Sulfonamides | 1 | 2003 | 300 | 0.190 |
Why?
|
| Research Report | 1 | 2021 | 44 | 0.190 |
Why?
|
| Organ Specificity | 2 | 2011 | 258 | 0.190 |
Why?
|
| Down-Regulation | 3 | 2021 | 504 | 0.190 |
Why?
|
| Squalene | 1 | 2000 | 1 | 0.190 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2017 | 16 | 0.190 |
Why?
|
| Recombinant Proteins | 8 | 2012 | 1014 | 0.190 |
Why?
|
| Liver Cirrhosis | 2 | 2020 | 297 | 0.190 |
Why?
|
| Spectrum Analysis | 2 | 1997 | 118 | 0.190 |
Why?
|
| Collagen Type VIII | 1 | 2020 | 1 | 0.190 |
Why?
|
| Receptors, Somatotropin | 1 | 2000 | 18 | 0.190 |
Why?
|
| Collagen Type XVIII | 1 | 2020 | 4 | 0.190 |
Why?
|
| Endostatins | 1 | 2020 | 6 | 0.190 |
Why?
|
| Lipogenesis | 1 | 2020 | 22 | 0.190 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2020 | 8 | 0.190 |
Why?
|
| Thrombospondin 1 | 1 | 2020 | 21 | 0.190 |
Why?
|
| Risk Assessment | 2 | 2018 | 2261 | 0.190 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2019 | 182 | 0.190 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 1801 | 0.190 |
Why?
|
| Hypoglycemic Agents | 3 | 2017 | 378 | 0.190 |
Why?
|
| Child | 7 | 2023 | 6926 | 0.190 |
Why?
|
| Actins | 3 | 2011 | 451 | 0.190 |
Why?
|
| Endothelium | 1 | 2020 | 59 | 0.180 |
Why?
|
| von Willebrand Factor | 2 | 2019 | 37 | 0.180 |
Why?
|
| Forecasting | 2 | 2013 | 304 | 0.180 |
Why?
|
| Proprotein Convertase 2 | 6 | 2007 | 11 | 0.180 |
Why?
|
| Adolescent | 6 | 2023 | 8979 | 0.180 |
Why?
|
| Complement Activation | 1 | 2020 | 81 | 0.180 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 93 | 0.180 |
Why?
|
| GTP-Binding Proteins | 3 | 2010 | 146 | 0.180 |
Why?
|
| ADAMTS13 Protein | 1 | 2019 | 3 | 0.180 |
Why?
|
| United Kingdom | 3 | 2019 | 164 | 0.180 |
Why?
|
| Cartilage | 3 | 2017 | 113 | 0.170 |
Why?
|
| Adenosine Triphosphatases | 3 | 2018 | 153 | 0.170 |
Why?
|
| Prediabetic State | 1 | 2019 | 39 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 7 | 2012 | 645 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 7 | 2012 | 305 | 0.170 |
Why?
|
| DNA Methylation | 1 | 2024 | 628 | 0.170 |
Why?
|
| Spermatozoa | 2 | 2011 | 62 | 0.170 |
Why?
|
| Transcription Factors, General | 1 | 2018 | 1 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2021 | 263 | 0.170 |
Why?
|
| Vesicular Transport Proteins | 2 | 2015 | 63 | 0.170 |
Why?
|
| Histones | 2 | 2024 | 311 | 0.170 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 117 | 0.170 |
Why?
|
| Heart Ventricles | 2 | 2021 | 760 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 96 | 0.170 |
Why?
|
| Cell Size | 2 | 2011 | 65 | 0.160 |
Why?
|
| Aquaporin 1 | 1 | 2018 | 5 | 0.160 |
Why?
|
| Tooth | 1 | 2018 | 50 | 0.160 |
Why?
|
| Mitochondria, Liver | 1 | 2018 | 27 | 0.160 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 68 | 0.160 |
Why?
|
| Response Elements | 2 | 2011 | 63 | 0.160 |
Why?
|
| Cell Differentiation | 7 | 2022 | 1458 | 0.160 |
Why?
|
| Spin Trapping | 2 | 2011 | 4 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 115 | 0.160 |
Why?
|
| Chromosome Mapping | 2 | 2021 | 1074 | 0.160 |
Why?
|
| alpha-2-HS-Glycoprotein | 1 | 2017 | 1 | 0.160 |
Why?
|
| Apolipoprotein C-III | 1 | 2017 | 8 | 0.160 |
Why?
|
| Air Pollution | 1 | 2019 | 68 | 0.160 |
Why?
|
| Glycopeptides | 1 | 2017 | 16 | 0.160 |
Why?
|
| Catalysis | 2 | 2021 | 203 | 0.160 |
Why?
|
| Growth Differentiation Factors | 1 | 2018 | 57 | 0.160 |
Why?
|
| Space-Time Clustering | 1 | 1997 | 3 | 0.160 |
Why?
|
| Entropy | 2 | 2010 | 38 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2022 | 395 | 0.160 |
Why?
|
| Genetic Vectors | 4 | 2003 | 439 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 3 | 2015 | 250 | 0.160 |
Why?
|
| Adipocytes | 3 | 2006 | 155 | 0.160 |
Why?
|
| Elastic Tissue | 1 | 2017 | 18 | 0.150 |
Why?
|
| Neurturin | 1 | 2017 | 1 | 0.150 |
Why?
|
| Liraglutide | 1 | 2017 | 5 | 0.150 |
Why?
|
| Substrate Specificity | 8 | 2012 | 347 | 0.150 |
Why?
|
| Extracellular Traps | 1 | 2017 | 11 | 0.150 |
Why?
|
| Fourier Analysis | 1 | 2017 | 125 | 0.150 |
Why?
|
| Homeostasis | 4 | 2019 | 409 | 0.150 |
Why?
|
| Hydrogenase | 1 | 2016 | 3 | 0.150 |
Why?
|
| Industrial Microbiology | 1 | 2016 | 2 | 0.150 |
Why?
|
| Arterial Pressure | 1 | 2017 | 38 | 0.150 |
Why?
|
| Genetic Variation | 2 | 2018 | 1351 | 0.150 |
Why?
|
| Organisms, Genetically Modified | 1 | 2016 | 9 | 0.150 |
Why?
|
| Rats, Inbred Strains | 8 | 2005 | 312 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2010 | 47 | 0.150 |
Why?
|
| Photosynthesis | 1 | 2016 | 54 | 0.150 |
Why?
|
| Chelating Agents | 1 | 2017 | 69 | 0.150 |
Why?
|
| Chlorophyll | 1 | 2016 | 47 | 0.150 |
Why?
|
| Tritium | 3 | 2012 | 133 | 0.150 |
Why?
|
| Ammonia | 1 | 2016 | 37 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2007 | 557 | 0.150 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2016 | 6 | 0.150 |
Why?
|
| Pancreas, Exocrine | 2 | 2017 | 18 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2019 | 303 | 0.150 |
Why?
|
| Insect Control | 1 | 2016 | 4 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 576 | 0.140 |
Why?
|
| Nitrogen | 1 | 2016 | 70 | 0.140 |
Why?
|
| Enzyme Inhibitors | 7 | 2005 | 639 | 0.140 |
Why?
|
| Clinical Studies as Topic | 1 | 2016 | 4 | 0.140 |
Why?
|
| Cyclic AMP | 5 | 2015 | 273 | 0.140 |
Why?
|
| Protein Kinases | 4 | 2006 | 209 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2022 | 7988 | 0.140 |
Why?
|
| HMGA1a Protein | 1 | 2016 | 3 | 0.140 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2016 | 5 | 0.140 |
Why?
|
| Lice Infestations | 1 | 2016 | 3 | 0.140 |
Why?
|
| Insecticide Resistance | 1 | 2016 | 9 | 0.140 |
Why?
|
| Snail Family Transcription Factors | 1 | 2016 | 26 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2001 | 85 | 0.140 |
Why?
|
| Spin Labels | 2 | 2011 | 102 | 0.140 |
Why?
|
| Nicotinic Agonists | 1 | 2017 | 72 | 0.140 |
Why?
|
| Synovitis | 1 | 2016 | 14 | 0.140 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2016 | 10 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2021 | 579 | 0.140 |
Why?
|
| Hemodynamics | 3 | 2018 | 710 | 0.140 |
Why?
|
| In Vitro Techniques | 9 | 2010 | 989 | 0.140 |
Why?
|
| Glucokinase | 1 | 2016 | 61 | 0.140 |
Why?
|
| Interleukin-1 | 3 | 2011 | 71 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 70 | 0.140 |
Why?
|
| Ubiquitination | 2 | 2020 | 67 | 0.140 |
Why?
|
| Joints | 1 | 2015 | 32 | 0.140 |
Why?
|
| Pancreatic Elastase | 2 | 2021 | 15 | 0.140 |
Why?
|
| Lacrimal Apparatus | 2 | 2005 | 11 | 0.140 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2015 | 30 | 0.130 |
Why?
|
| Mutation | 7 | 2018 | 3967 | 0.130 |
Why?
|
| Surface Plasmon Resonance | 2 | 2012 | 46 | 0.130 |
Why?
|
| Protease Inhibitors | 3 | 1992 | 72 | 0.130 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 44 | 0.130 |
Why?
|
| Nicotine | 1 | 2017 | 194 | 0.130 |
Why?
|
| Adenine | 1 | 2015 | 85 | 0.130 |
Why?
|
| Testis | 3 | 2012 | 152 | 0.130 |
Why?
|
| Subcellular Fractions | 4 | 2011 | 93 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2017 | 240 | 0.130 |
Why?
|
| Rotator Cuff Injuries | 1 | 2016 | 46 | 0.130 |
Why?
|
| Parabrachial Nucleus | 1 | 2014 | 1 | 0.130 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2014 | 7 | 0.130 |
Why?
|
| Appetite Regulation | 1 | 2014 | 9 | 0.130 |
Why?
|
| Guanylate Cyclase | 1 | 2014 | 18 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 22 | 0.130 |
Why?
|
| Altitude Sickness | 1 | 2014 | 10 | 0.130 |
Why?
|
| Microscopy, Confocal | 5 | 2011 | 268 | 0.130 |
Why?
|
| Caspases | 3 | 2005 | 155 | 0.130 |
Why?
|
| Disease | 1 | 2015 | 90 | 0.130 |
Why?
|
| Light | 2 | 2013 | 289 | 0.130 |
Why?
|
| Amidohydrolases | 1 | 2014 | 18 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 1990 | 0.130 |
Why?
|
| Ephrin-A1 | 1 | 2014 | 1 | 0.130 |
Why?
|
| Dexamethasone | 2 | 1996 | 326 | 0.130 |
Why?
|
| Receptor, EphA2 | 1 | 2014 | 6 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2023 | 493 | 0.120 |
Why?
|
| Asthma | 1 | 2022 | 955 | 0.120 |
Why?
|
| Stroke Volume | 1 | 2017 | 456 | 0.120 |
Why?
|
| Macrophages | 1 | 2017 | 554 | 0.120 |
Why?
|
| Environmental Health | 1 | 2014 | 7 | 0.120 |
Why?
|
| Exercise | 2 | 2023 | 315 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 122 | 0.120 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 2016 | 15 | 0.120 |
Why?
|
| Thymidine | 3 | 2005 | 59 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 927 | 0.120 |
Why?
|
| Proprotein Convertase 1 | 3 | 2017 | 11 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2014 | 42 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2014 | 107 | 0.120 |
Why?
|
| Disasters | 1 | 2014 | 20 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2013 | 33 | 0.120 |
Why?
|
| Oligopeptides | 2 | 1992 | 179 | 0.120 |
Why?
|
| Distemper | 1 | 2013 | 1 | 0.120 |
Why?
|
| Distemper Virus, Canine | 1 | 2013 | 2 | 0.120 |
Why?
|
| Proprotein Convertases | 5 | 1996 | 26 | 0.120 |
Why?
|
| Rabies | 1 | 2013 | 7 | 0.120 |
Why?
|
| Caspase 9 | 2 | 2003 | 48 | 0.120 |
Why?
|
| Japan | 1 | 2014 | 307 | 0.120 |
Why?
|
| Endocytosis | 1 | 2014 | 177 | 0.110 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 109 | 0.110 |
Why?
|
| Hyperlipidemias | 2 | 2005 | 95 | 0.110 |
Why?
|
| Angiopoietins | 1 | 2013 | 6 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 470 | 0.110 |
Why?
|
| Aerobiosis | 1 | 2013 | 17 | 0.110 |
Why?
|
| Natriuretic Peptides | 1 | 2013 | 6 | 0.110 |
Why?
|
| London | 1 | 2012 | 16 | 0.110 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2013 | 27 | 0.110 |
Why?
|
| Genes, Reporter | 5 | 2009 | 268 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 123 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 4 | 2006 | 503 | 0.110 |
Why?
|
| Petroleum Pollution | 1 | 2013 | 11 | 0.110 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2012 | 1 | 0.110 |
Why?
|
| Zinc Transporter 8 | 1 | 2012 | 2 | 0.110 |
Why?
|
| Pyridines | 3 | 2011 | 309 | 0.110 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2012 | 3 | 0.110 |
Why?
|
| Proteostasis Deficiencies | 1 | 2012 | 3 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2012 | 96 | 0.110 |
Why?
|
| Pancreatic Hormones | 1 | 2012 | 15 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2016 | 548 | 0.110 |
Why?
|
| Neprilysin | 1 | 2012 | 42 | 0.110 |
Why?
|
| Glutamate Decarboxylase | 1 | 2012 | 32 | 0.110 |
Why?
|
| Temperature | 3 | 2004 | 396 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2014 | 278 | 0.110 |
Why?
|
| Spermatocytes | 1 | 2012 | 8 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2017 | 315 | 0.110 |
Why?
|
| Spermatogonia | 1 | 2012 | 13 | 0.110 |
Why?
|
| Superoxide Dismutase | 3 | 2022 | 177 | 0.110 |
Why?
|
| Fungi | 1 | 2013 | 65 | 0.110 |
Why?
|
| Paraffin Embedding | 1 | 2012 | 78 | 0.110 |
Why?
|
| Age Distribution | 1 | 2012 | 204 | 0.110 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 32 | 0.110 |
Why?
|
| Uric Acid | 1 | 2013 | 139 | 0.110 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2012 | 15 | 0.110 |
Why?
|
| Isoquinolines | 3 | 2012 | 72 | 0.110 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2012 | 42 | 0.110 |
Why?
|
| Incineration | 1 | 2012 | 1 | 0.110 |
Why?
|
| Agricultural Inoculants | 1 | 2012 | 1 | 0.110 |
Why?
|
| Radioactivity | 1 | 2012 | 4 | 0.110 |
Why?
|
| Immunoblotting | 4 | 2010 | 268 | 0.110 |
Why?
|
| Arginine | 3 | 2014 | 136 | 0.110 |
Why?
|
| Fluorometry | 1 | 1992 | 30 | 0.110 |
Why?
|
| Fossil Fuels | 1 | 2012 | 3 | 0.110 |
Why?
|
| Explosions | 1 | 2012 | 6 | 0.110 |
Why?
|
| Trans-Activators | 4 | 2004 | 429 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 999 | 0.110 |
Why?
|
| Fertilizers | 1 | 2012 | 8 | 0.110 |
Why?
|
| Autopsy | 1 | 2012 | 116 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 1041 | 0.110 |
Why?
|
| Immunization, Secondary | 1 | 2012 | 30 | 0.110 |
Why?
|
| Membranes, Artificial | 1 | 2012 | 40 | 0.110 |
Why?
|
| Plant Development | 1 | 2012 | 8 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 41 | 0.110 |
Why?
|
| Biological Assay | 1 | 2012 | 78 | 0.110 |
Why?
|
| Deuterium | 1 | 2012 | 33 | 0.110 |
Why?
|
| Soil Microbiology | 1 | 2012 | 21 | 0.110 |
Why?
|
| Geologic Sediments | 1 | 2012 | 19 | 0.110 |
Why?
|
| Indoles | 6 | 2003 | 318 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 623 | 0.110 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 64 | 0.100 |
Why?
|
| Neutrons | 1 | 2012 | 58 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 663 | 0.100 |
Why?
|
| Deoxyguanosine | 2 | 2018 | 28 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2011 | 10 | 0.100 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Microbial Consortia | 1 | 2012 | 13 | 0.100 |
Why?
|
| Acetamides | 1 | 2011 | 26 | 0.100 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2012 | 143 | 0.100 |
Why?
|
| Neurotensin | 1 | 2011 | 10 | 0.100 |
Why?
|
| Gold | 1 | 2012 | 41 | 0.100 |
Why?
|
| Malonyl Coenzyme A | 2 | 2004 | 4 | 0.100 |
Why?
|
| Animal Husbandry | 1 | 2012 | 25 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2011 | 10 | 0.100 |
Why?
|
| Receptors, Transferrin | 1 | 2011 | 10 | 0.100 |
Why?
|
| Hepcidins | 1 | 2011 | 4 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2013 | 476 | 0.100 |
Why?
|
| Immunoglobulin M | 1 | 2012 | 154 | 0.100 |
Why?
|
| Milk Proteins | 2 | 2003 | 24 | 0.100 |
Why?
|
| Lasers | 1 | 2012 | 106 | 0.100 |
Why?
|
| Equipment Design | 1 | 2013 | 406 | 0.100 |
Why?
|
| Appetite | 2 | 2021 | 26 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 48 | 0.100 |
Why?
|
| Ferritins | 1 | 2011 | 29 | 0.100 |
Why?
|
| International Cooperation | 1 | 2012 | 127 | 0.100 |
Why?
|
| Dietary Supplements | 2 | 2023 | 128 | 0.100 |
Why?
|
| Dopamine | 2 | 2011 | 275 | 0.100 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 1 | 2011 | 2 | 0.100 |
Why?
|
| Preoptic Area | 1 | 2011 | 6 | 0.100 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 59 | 0.100 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 54 | 0.100 |
Why?
|
| Mice, Obese | 3 | 2021 | 44 | 0.100 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2011 | 11 | 0.100 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2011 | 9 | 0.100 |
Why?
|
| Food Irradiation | 1 | 2011 | 3 | 0.100 |
Why?
|
| Recycling | 1 | 2011 | 2 | 0.100 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2010 | 2 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2012 | 206 | 0.100 |
Why?
|
| Nanostructures | 1 | 2012 | 77 | 0.100 |
Why?
|
| Poisons | 1 | 2011 | 8 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2011 | 91 | 0.100 |
Why?
|
| Alleles | 3 | 2024 | 1127 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 81 | 0.100 |
Why?
|
| Biotechnology | 1 | 2011 | 28 | 0.100 |
Why?
|
| Growth Hormone | 2 | 2002 | 97 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 42 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2006 | 302 | 0.100 |
Why?
|
| Radiometry | 1 | 2011 | 53 | 0.100 |
Why?
|
| Catalase | 2 | 2022 | 48 | 0.100 |
Why?
|
| Antigenic Variation | 1 | 2010 | 26 | 0.100 |
Why?
|
| Genotype | 4 | 2023 | 1850 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 203 | 0.100 |
Why?
|
| Somatostatin | 2 | 2002 | 55 | 0.100 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.100 |
Why?
|
| Genetic Drift | 1 | 2010 | 37 | 0.090 |
Why?
|
| Rhombencephalon | 2 | 2014 | 50 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 179 | 0.090 |
Why?
|
| Cell Fractionation | 4 | 2002 | 71 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 65 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 2 | 2001 | 71 | 0.090 |
Why?
|
| Oceans and Seas | 1 | 2010 | 30 | 0.090 |
Why?
|
| ROC Curve | 1 | 2012 | 752 | 0.090 |
Why?
|
| Vitamins | 1 | 2011 | 81 | 0.090 |
Why?
|
| Dihydroxyacetone Phosphate | 2 | 2001 | 2 | 0.090 |
Why?
|
| Oximetry | 1 | 2011 | 84 | 0.090 |
Why?
|
| Glycerophosphates | 2 | 2001 | 5 | 0.090 |
Why?
|
| Arsenites | 1 | 2010 | 6 | 0.090 |
Why?
|
| Chromates | 1 | 2010 | 2 | 0.090 |
Why?
|
| Cyanides | 1 | 2010 | 16 | 0.090 |
Why?
|
| Iodides | 1 | 2010 | 18 | 0.090 |
Why?
|
| Maleimides | 4 | 2003 | 29 | 0.090 |
Why?
|
| Caspase 3 | 3 | 2009 | 159 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2012 | 290 | 0.090 |
Why?
|
| Receptors, Glucagon | 2 | 2010 | 11 | 0.090 |
Why?
|
| Adsorption | 1 | 2010 | 54 | 0.090 |
Why?
|
| Creatinine | 1 | 2011 | 338 | 0.090 |
Why?
|
| Cell Membrane | 6 | 2014 | 666 | 0.090 |
Why?
|
| Solutions | 1 | 2010 | 85 | 0.090 |
Why?
|
| Arsenic Poisoning | 1 | 2011 | 103 | 0.090 |
Why?
|
| Phenotype | 4 | 2017 | 2377 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 232 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2019 | 306 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2023 | 547 | 0.090 |
Why?
|
| Infant | 2 | 2016 | 3045 | 0.090 |
Why?
|
| Pregnancy | 3 | 2022 | 2893 | 0.090 |
Why?
|
| Simvastatin | 1 | 2010 | 106 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 20 | 0.090 |
Why?
|
| Prealbumin | 1 | 1989 | 34 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2016 | 378 | 0.090 |
Why?
|
| Antihypertensive Agents | 2 | 2011 | 521 | 0.090 |
Why?
|
| Amygdala | 1 | 2010 | 84 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2004 | 131 | 0.090 |
Why?
|
| Neural Pathways | 4 | 2014 | 308 | 0.090 |
Why?
|
| Population Dynamics | 1 | 2010 | 130 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 428 | 0.090 |
Why?
|
| Sex Attractants | 1 | 2009 | 5 | 0.090 |
Why?
|
| Cocaine | 1 | 2010 | 76 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 64 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 683 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 178 | 0.090 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 408 | 0.090 |
Why?
|
| Amphetamine | 1 | 2010 | 101 | 0.090 |
Why?
|
| Blood | 3 | 2000 | 69 | 0.090 |
Why?
|
| Adrenomedullin | 1 | 2008 | 5 | 0.090 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2008 | 5 | 0.090 |
Why?
|
| Basic Reproduction Number | 1 | 2008 | 6 | 0.090 |
Why?
|
| Albumins | 1 | 1989 | 133 | 0.080 |
Why?
|
| Stimulation, Chemical | 2 | 2005 | 63 | 0.080 |
Why?
|
| Enteroendocrine Cells | 1 | 2008 | 6 | 0.080 |
Why?
|
| Bacteria | 1 | 2013 | 447 | 0.080 |
Why?
|
| Dichloroacetic Acid | 1 | 2008 | 11 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2004 | 1208 | 0.080 |
Why?
|
| Receptors, Odorant | 1 | 2009 | 37 | 0.080 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 103 | 0.080 |
Why?
|
| Schools | 1 | 2009 | 71 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2020 | 103 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 193 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 536 | 0.080 |
Why?
|
| DNA Primers | 4 | 2006 | 543 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2020 | 276 | 0.080 |
Why?
|
| Wales | 1 | 2008 | 10 | 0.080 |
Why?
|
| Serine Endopeptidases | 3 | 1993 | 145 | 0.080 |
Why?
|
| Diet | 2 | 2021 | 443 | 0.080 |
Why?
|
| England | 1 | 2008 | 41 | 0.080 |
Why?
|
| Mice, Inbred DBA | 5 | 2017 | 148 | 0.080 |
Why?
|
| Keratinocytes | 2 | 2006 | 143 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2022 | 267 | 0.080 |
Why?
|
| Arsenic | 1 | 2011 | 251 | 0.080 |
Why?
|
| C-Peptide | 1 | 1988 | 174 | 0.080 |
Why?
|
| Markov Chains | 1 | 2008 | 125 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2017 | 68 | 0.080 |
Why?
|
| Lysine | 2 | 2024 | 147 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 153 | 0.080 |
Why?
|
| Binding, Competitive | 2 | 2011 | 145 | 0.080 |
Why?
|
| Intestines | 1 | 2010 | 411 | 0.080 |
Why?
|
| Carboxypeptidases | 5 | 1996 | 35 | 0.080 |
Why?
|
| Rats, Zucker | 3 | 2017 | 38 | 0.080 |
Why?
|
| rho-Associated Kinases | 1 | 2008 | 159 | 0.080 |
Why?
|
| Serotonin | 1 | 2008 | 218 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 1621 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2009 | 444 | 0.070 |
Why?
|
| Ventricular Function, Right | 2 | 2019 | 142 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 219 | 0.070 |
Why?
|
| Pneumonia | 1 | 2008 | 179 | 0.070 |
Why?
|
| Coronary Circulation | 2 | 2002 | 130 | 0.070 |
Why?
|
| Glucagon-Like Peptides | 2 | 2004 | 8 | 0.070 |
Why?
|
| RNA Splicing | 1 | 1988 | 142 | 0.070 |
Why?
|
| Antiporters | 1 | 2006 | 18 | 0.070 |
Why?
|
| Sexual Behavior, Animal | 1 | 2007 | 92 | 0.070 |
Why?
|
| Lipid Metabolism | 2 | 2005 | 196 | 0.070 |
Why?
|
| Chromones | 4 | 2010 | 28 | 0.070 |
Why?
|
| Organic Anion Transporters | 1 | 2006 | 27 | 0.070 |
Why?
|
| Integrins | 1 | 2006 | 76 | 0.070 |
Why?
|
| Mesoderm | 1 | 2007 | 108 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2378 | 0.070 |
Why?
|
| Morpholines | 4 | 2010 | 65 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 351 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2014 | 2426 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2006 | 122 | 0.070 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2005 | 5 | 0.070 |
Why?
|
| Necrosis | 2 | 2005 | 204 | 0.070 |
Why?
|
| Metals, Heavy | 1 | 2006 | 15 | 0.070 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2005 | 28 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2018 | 134 | 0.070 |
Why?
|
| Carcinogens | 1 | 2006 | 108 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2007 | 201 | 0.070 |
Why?
|
| Skin | 2 | 2006 | 554 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 231 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 1985 | 22 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 1195 | 0.070 |
Why?
|
| Satiety Response | 1 | 2005 | 4 | 0.070 |
Why?
|
| Hydroxybutyrates | 1 | 1985 | 27 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3352 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 3611 | 0.070 |
Why?
|
| Chick Embryo | 3 | 1996 | 229 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2005 | 89 | 0.070 |
Why?
|
| Oligoribonucleotides | 1 | 1985 | 28 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 294 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2004 | 2 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 72 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 1985 | 63 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 246 | 0.060 |
Why?
|
| Interferons | 1 | 1985 | 133 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2004 | 141 | 0.060 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2004 | 8 | 0.060 |
Why?
|
| Eye Proteins | 1 | 2005 | 128 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2004 | 35 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 1985 | 92 | 0.060 |
Why?
|
| Mammals | 2 | 2004 | 227 | 0.060 |
Why?
|
| Acyl Coenzyme A | 1 | 2004 | 17 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2018 | 615 | 0.060 |
Why?
|
| Vitamin E | 1 | 2004 | 35 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 199 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 214 | 0.060 |
Why?
|
| Endoribonucleases | 1 | 1985 | 92 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2003 | 5 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 125 | 0.060 |
Why?
|
| Carboxypeptidase H | 5 | 1996 | 12 | 0.060 |
Why?
|
| Interferon Type I | 1 | 1984 | 175 | 0.060 |
Why?
|
| Egtazic Acid | 2 | 2002 | 34 | 0.060 |
Why?
|
| Rodentia | 1 | 2024 | 42 | 0.060 |
Why?
|
| Diazoxide | 1 | 2003 | 19 | 0.060 |
Why?
|
| Serine | 1 | 2024 | 99 | 0.060 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 65 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1996 | 266 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2014 | 329 | 0.060 |
Why?
|
| HMGB Proteins | 1 | 2023 | 3 | 0.060 |
Why?
|
| Insulin, Regular, Human | 1 | 2023 | 7 | 0.060 |
Why?
|
| Benzopyrans | 1 | 2003 | 20 | 0.060 |
Why?
|
| Spermidine | 1 | 2023 | 6 | 0.060 |
Why?
|
| Acetophenones | 1 | 2003 | 27 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1531 | 0.060 |
Why?
|
| Immunoprecipitation | 3 | 2011 | 134 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 3 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2003 | 83 | 0.060 |
Why?
|
| Verapamil | 1 | 2003 | 48 | 0.060 |
Why?
|
| Protein Conformation | 3 | 2014 | 881 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2007 | 502 | 0.060 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2023 | 41 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2023 | 73 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2020 | 242 | 0.060 |
Why?
|
| Cyclins | 1 | 2003 | 82 | 0.060 |
Why?
|
| Chemokine CXCL10 | 1 | 2022 | 17 | 0.060 |
Why?
|
| Cobalt | 1 | 2022 | 29 | 0.060 |
Why?
|
| Molybdenum | 1 | 2022 | 12 | 0.060 |
Why?
|
| Chromium | 1 | 2022 | 17 | 0.060 |
Why?
|
| Malates | 1 | 2002 | 5 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2023 | 83 | 0.060 |
Why?
|
| Lymphotoxin-alpha | 1 | 2022 | 44 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 864 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2022 | 46 | 0.060 |
Why?
|
| Periodicity | 1 | 2003 | 119 | 0.060 |
Why?
|
| Body Temperature | 2 | 2014 | 124 | 0.050 |
Why?
|
| Netrins | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 107 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2002 | 17 | 0.050 |
Why?
|
| Nucleoside-Diphosphate Kinase | 2 | 1999 | 11 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2024 | 182 | 0.050 |
Why?
|
| Fumarates | 1 | 2002 | 26 | 0.050 |
Why?
|
| Guanosine Triphosphate | 2 | 1999 | 38 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 599 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2022 | 14 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2002 | 49 | 0.050 |
Why?
|
| Ions | 1 | 2022 | 74 | 0.050 |
Why?
|
| Casein Kinase II | 1 | 2002 | 11 | 0.050 |
Why?
|
| Lipids | 1 | 2004 | 269 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2002 | 29 | 0.050 |
Why?
|
| Chemical Phenomena | 1 | 2002 | 72 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 103 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 57 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1823 | 0.050 |
Why?
|
| Placenta Growth Factor | 1 | 2022 | 70 | 0.050 |
Why?
|
| Lateral Ventricles | 1 | 2022 | 12 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 91 | 0.050 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 34 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 427 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 177 | 0.050 |
Why?
|
| Reference Values | 2 | 2019 | 674 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2021 | 35 | 0.050 |
Why?
|
| Overweight | 1 | 2023 | 118 | 0.050 |
Why?
|
| Melanocortins | 1 | 2021 | 4 | 0.050 |
Why?
|
| Anorexia | 1 | 2001 | 30 | 0.050 |
Why?
|
| Guanine Nucleotides | 1 | 2001 | 14 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 187 | 0.050 |
Why?
|
| Coumaric Acids | 1 | 2001 | 6 | 0.050 |
Why?
|
| Carbachol | 3 | 2005 | 34 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 77 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 71 | 0.050 |
Why?
|
| Lactates | 1 | 2001 | 37 | 0.050 |
Why?
|
| Sex Factors | 2 | 2020 | 1054 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1991 | 109 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 2 | 2015 | 87 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2001 | 53 | 0.050 |
Why?
|
| Energy Intake | 1 | 2021 | 98 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 4 | 0.050 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2021 | 3 | 0.050 |
Why?
|
| Phosphates | 1 | 2002 | 160 | 0.050 |
Why?
|
| Phylogeny | 2 | 2018 | 1137 | 0.050 |
Why?
|
| Orexins | 2 | 2011 | 8 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 76 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 21 | 0.050 |
Why?
|
| Lipase | 1 | 2021 | 22 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2021 | 102 | 0.050 |
Why?
|
| Organ of Corti | 1 | 2001 | 10 | 0.050 |
Why?
|
| Heart Failure | 1 | 2011 | 1203 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 281 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 341 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2001 | 43 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2004 | 256 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 80 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 376 | 0.050 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 1971 | 10 | 0.050 |
Why?
|
| Cell Death | 2 | 2014 | 256 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2021 | 38 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 85 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2011 | 37 | 0.050 |
Why?
|
| Cytosol | 2 | 2006 | 189 | 0.050 |
Why?
|
| Radioimmunoassay | 2 | 1993 | 155 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 679 | 0.050 |
Why?
|
| Cholesterol | 1 | 2023 | 356 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 193 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2705 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 133 | 0.050 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2000 | 3 | 0.050 |
Why?
|
| Sialic Acids | 1 | 2020 | 18 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 165 | 0.050 |
Why?
|
| Brain Stem | 1 | 2021 | 165 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 879 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2020 | 34 | 0.050 |
Why?
|
| Erythrocyte Indices | 1 | 2020 | 10 | 0.050 |
Why?
|
| Complement Factor B | 1 | 2020 | 9 | 0.050 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 13 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2000 | 41 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2021 | 287 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 399 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 381 | 0.050 |
Why?
|
| Complement C5 | 1 | 2020 | 14 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 72 | 0.050 |
Why?
|
| Glycogen | 1 | 2020 | 59 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 48 | 0.050 |
Why?
|
| Organometallic Compounds | 1 | 2021 | 132 | 0.050 |
Why?
|
| Complement C3 | 1 | 2020 | 58 | 0.050 |
Why?
|
| Weight Loss | 1 | 2021 | 229 | 0.050 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 1999 | 18 | 0.050 |
Why?
|
| Genes, jun | 2 | 1998 | 18 | 0.050 |
Why?
|
| Genes, fos | 2 | 1998 | 24 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1999 | 49 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 112 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2000 | 58 | 0.040 |
Why?
|
| Primates | 1 | 2021 | 151 | 0.040 |
Why?
|
| Nitrogen Dioxide | 1 | 2019 | 11 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2009 | 28 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2023 | 770 | 0.040 |
Why?
|
| COP-Coated Vesicles | 1 | 2019 | 22 | 0.040 |
Why?
|
| Biological Transport | 3 | 2006 | 396 | 0.040 |
Why?
|
| Focal Adhesions | 1 | 2020 | 69 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2017 | 324 | 0.040 |
Why?
|
| Exosomes | 1 | 2020 | 50 | 0.040 |
Why?
|
| Heart | 1 | 2002 | 539 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2000 | 135 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1996 | 108 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2020 | 148 | 0.040 |
Why?
|
| Kallikrein-Kinin System | 1 | 2018 | 1 | 0.040 |
Why?
|
| Body Patterning | 1 | 2001 | 209 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 133 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2013 | 420 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 2 | 2011 | 8 | 0.040 |
Why?
|
| Odontogenesis | 1 | 2018 | 13 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 365 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 171 | 0.040 |
Why?
|
| ras Proteins | 1 | 1999 | 128 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 79 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 48 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2018 | 35 | 0.040 |
Why?
|
| Rats, Inbred SHR | 1 | 1998 | 29 | 0.040 |
Why?
|
| Rats, Inbred WKY | 1 | 1998 | 31 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2016 | 712 | 0.040 |
Why?
|
| Keto Acids | 1 | 1998 | 6 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2019 | 79 | 0.040 |
Why?
|
| Tolbutamide | 2 | 1996 | 16 | 0.040 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Agouti-Related Protein | 1 | 2018 | 4 | 0.040 |
Why?
|
| Dietary Sugars | 1 | 2018 | 8 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 1998 | 12 | 0.040 |
Why?
|
| Pharmaceutic Aids | 1 | 1998 | 2 | 0.040 |
Why?
|
| Oils | 1 | 1998 | 6 | 0.040 |
Why?
|
| Oleic Acid | 1 | 1998 | 14 | 0.040 |
Why?
|
| Neuropeptide Y | 1 | 2018 | 31 | 0.040 |
Why?
|
| Hormone Antagonists | 1 | 1998 | 20 | 0.040 |
Why?
|
| Fructose | 1 | 2018 | 35 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 228 | 0.040 |
Why?
|
| Chromatin | 1 | 2021 | 380 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2018 | 135 | 0.040 |
Why?
|
| Carbohydrate Sequence | 1 | 2017 | 20 | 0.040 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2018 | 48 | 0.040 |
Why?
|
| Mumps | 1 | 1997 | 2 | 0.040 |
Why?
|
| Whooping Cough | 1 | 1997 | 3 | 0.040 |
Why?
|
| Incidence | 2 | 2004 | 1576 | 0.040 |
Why?
|
| Population | 1 | 1998 | 35 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 1997 | 4 | 0.040 |
Why?
|
| Lactic Acid | 1 | 1998 | 90 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 2001 | 646 | 0.040 |
Why?
|
| Cadherins | 1 | 2018 | 151 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 76 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 421 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 596 | 0.040 |
Why?
|
| Fibrillin-1 | 1 | 2017 | 1 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2017 | 2 | 0.040 |
Why?
|
| Microinjections | 2 | 2011 | 70 | 0.040 |
Why?
|
| Elastin | 1 | 2017 | 7 | 0.040 |
Why?
|
| Sirolimus | 1 | 2019 | 169 | 0.040 |
Why?
|
| Glycosylation | 1 | 2017 | 129 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 15 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1998 | 303 | 0.040 |
Why?
|
| Genome | 1 | 2020 | 372 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 1997 | 74 | 0.040 |
Why?
|
| Infusions, Subcutaneous | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 55 | 0.040 |
Why?
|
| Chlorine Compounds | 1 | 1997 | 1 | 0.040 |
Why?
|
| Glycolysis | 1 | 1998 | 129 | 0.040 |
Why?
|
| Chlorine | 1 | 1997 | 8 | 0.040 |
Why?
|
| Peroxidase | 1 | 2017 | 51 | 0.040 |
Why?
|
| Heparin | 1 | 1998 | 175 | 0.040 |
Why?
|
| Arthritis, Experimental | 1 | 2017 | 24 | 0.040 |
Why?
|
| Metformin | 1 | 2019 | 128 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2011 | 188 | 0.040 |
Why?
|
| Oxides | 1 | 1997 | 43 | 0.040 |
Why?
|
| Leucine | 2 | 1988 | 67 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1996 | 73 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 3636 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2017 | 369 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 449 | 0.040 |
Why?
|
| alpha-MSH | 2 | 2010 | 4 | 0.040 |
Why?
|
| Procollagen | 1 | 1996 | 8 | 0.040 |
Why?
|
| Viral Proteins | 1 | 1998 | 300 | 0.040 |
Why?
|
| Lisuride | 1 | 2016 | 1 | 0.040 |
Why?
|
| Phentolamine | 1 | 2016 | 7 | 0.040 |
Why?
|
| Potassium Channels | 1 | 1998 | 340 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 194 | 0.040 |
Why?
|
| Ovum | 1 | 2016 | 58 | 0.040 |
Why?
|
| Pyrethrins | 1 | 2016 | 10 | 0.040 |
Why?
|
| Binding Sites | 3 | 2003 | 1098 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 860 | 0.040 |
Why?
|
| United States | 2 | 2021 | 6665 | 0.040 |
Why?
|
| Exopeptidases | 1 | 1996 | 1 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 364 | 0.040 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2017 | 50 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2016 | 28 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 44 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 32 | 0.030 |
Why?
|
| Saliva | 1 | 1997 | 122 | 0.030 |
Why?
|
| Thrombosis | 1 | 2019 | 296 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 46 | 0.030 |
Why?
|
| Citrulline | 1 | 2015 | 10 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1996 | 132 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 369 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1996 | 28 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1996 | 66 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 1996 | 64 | 0.030 |
Why?
|
| 3T3-L1 Cells | 2 | 2006 | 32 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 224 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 1996 | 100 | 0.030 |
Why?
|
| Base Composition | 1 | 1995 | 35 | 0.030 |
Why?
|
| Neutrophils | 1 | 2017 | 307 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2017 | 217 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1995 | 129 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1185 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1993 | 268 | 0.030 |
Why?
|
| Intracellular Membranes | 2 | 2006 | 117 | 0.030 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2014 | 1 | 0.030 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 1994 | 2 | 0.030 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2014 | 2 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 154 | 0.030 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 2 | 1992 | 6 | 0.030 |
Why?
|
| Nitriles | 2 | 2006 | 149 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 279 | 0.030 |
Why?
|
| Electroporation | 1 | 1994 | 55 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1376 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 173 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1995 | 210 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 193 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1998 | 408 | 0.030 |
Why?
|
| Sf9 Cells | 1 | 2014 | 7 | 0.030 |
Why?
|
| Membrane Potentials | 3 | 2004 | 435 | 0.030 |
Why?
|
| ADAM10 Protein | 1 | 2014 | 7 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 135 | 0.030 |
Why?
|
| Spodoptera | 1 | 2014 | 32 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 8 | 0.030 |
Why?
|
| Clathrin | 1 | 2014 | 29 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 74 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 2014 | 17 | 0.030 |
Why?
|
| Rabbits | 2 | 2005 | 636 | 0.030 |
Why?
|
| Introns | 1 | 1995 | 289 | 0.030 |
Why?
|
| Expert Testimony | 1 | 2014 | 46 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 241 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 49 | 0.030 |
Why?
|
| Oxytocin | 1 | 2014 | 71 | 0.030 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 56 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 458 | 0.030 |
Why?
|
| Dynamins | 1 | 2014 | 49 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 93 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 351 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 83 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1995 | 782 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 307 | 0.030 |
Why?
|
| Foxes | 1 | 2013 | 2 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2014 | 116 | 0.030 |
Why?
|
| Prevalence | 1 | 1997 | 1239 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 34 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2014 | 249 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 51 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 39 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2007 | 393 | 0.030 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1992 | 20 | 0.030 |
Why?
|
| Italy | 1 | 2013 | 106 | 0.030 |
Why?
|
| Cricetinae | 2 | 2010 | 560 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 207 | 0.030 |
Why?
|
| Nuclear Matrix | 1 | 1992 | 3 | 0.030 |
Why?
|
| Dwarfism | 1 | 1992 | 16 | 0.030 |
Why?
|
| Smoking | 1 | 2017 | 609 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 433 | 0.030 |
Why?
|
| Homozygote | 2 | 2005 | 200 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 151 | 0.030 |
Why?
|
| Naphthols | 1 | 2012 | 4 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 128 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 3 | 1998 | 396 | 0.030 |
Why?
|
| Leydig Cells | 1 | 2012 | 11 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 736 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2014 | 457 | 0.030 |
Why?
|
| Amino Acids, Diamino | 1 | 1992 | 2 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 2012 | 9 | 0.030 |
Why?
|
| Cations | 1 | 1992 | 30 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 114 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2011 | 32 | 0.030 |
Why?
|
| Microtomy | 1 | 2011 | 10 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 147 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2005 | 281 | 0.030 |
Why?
|
| Triazines | 1 | 2012 | 53 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 2 | 2003 | 42 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2011 | 77 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2011 | 12 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2011 | 5 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1991 | 135 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 276 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2014 | 403 | 0.030 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2011 | 1 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 502 | 0.020 |
Why?
|
| Mutagens | 1 | 2011 | 31 | 0.020 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 1 | 2010 | 1 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 92 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2011 | 149 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 853 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 456 | 0.020 |
Why?
|
| Collagen | 1 | 1992 | 269 | 0.020 |
Why?
|
| Luciferases | 2 | 2003 | 118 | 0.020 |
Why?
|
| Arsenicals | 1 | 2011 | 48 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 91 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 236 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 2 | 2001 | 9 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2011 | 157 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 401 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 4210 | 0.020 |
Why?
|
| Protons | 2 | 1989 | 98 | 0.020 |
Why?
|
| Androstadienes | 1 | 2010 | 72 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2011 | 104 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 339 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1992 | 91 | 0.020 |
Why?
|
| Fourth Ventricle | 1 | 2010 | 1 | 0.020 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2010 | 2 | 0.020 |
Why?
|
| Decerebrate State | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 126 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Prenylation | 1 | 2010 | 3 | 0.020 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2010 | 33 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 187 | 0.020 |
Why?
|
| Perinatology | 1 | 1990 | 14 | 0.020 |
Why?
|
| Computer Communication Networks | 1 | 1990 | 23 | 0.020 |
Why?
|
| Aconitate Hydratase | 1 | 2009 | 11 | 0.020 |
Why?
|
| Comet Assay | 1 | 2009 | 9 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2001 | 125 | 0.020 |
Why?
|
| Protein Kinase C beta | 2 | 2000 | 16 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 479 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1991 | 498 | 0.020 |
Why?
|
| Nitrites | 1 | 2009 | 30 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2009 | 4 | 0.020 |
Why?
|
| Computer Systems | 1 | 1990 | 79 | 0.020 |
Why?
|
| Vagotomy | 1 | 2009 | 12 | 0.020 |
Why?
|
| Genes, ras | 1 | 2010 | 96 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2009 | 5 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2009 | 14 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2009 | 39 | 0.020 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Palmitates | 1 | 2009 | 18 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 53 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 329 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 1989 | 93 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2009 | 36 | 0.020 |
Why?
|
| Sulfonium Compounds | 1 | 1989 | 1 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2357 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 78 | 0.020 |
Why?
|
| Exons | 1 | 1991 | 450 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2011 | 226 | 0.020 |
Why?
|
| Pseudogenes | 1 | 1989 | 35 | 0.020 |
Why?
|
| Axons | 1 | 2010 | 174 | 0.020 |
Why?
|
| Sphingosine | 1 | 2009 | 71 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 327 | 0.020 |
Why?
|
| Laminin | 1 | 1989 | 85 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2009 | 69 | 0.020 |
Why?
|
| Synapses | 1 | 2011 | 265 | 0.020 |
Why?
|
| Poly A | 1 | 1988 | 23 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2009 | 273 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 1988 | 34 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6501 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1989 | 135 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 1988 | 48 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2000 | 144 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| Dicyclohexylcarbodiimide | 1 | 1987 | 1 | 0.020 |
Why?
|
| Trialkyltin Compounds | 1 | 1987 | 1 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 819 | 0.020 |
Why?
|
| Secretory Rate | 1 | 1987 | 13 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 112 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 695 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 589 | 0.020 |
Why?
|
| Tricarboxylic Acids | 1 | 2006 | 1 | 0.020 |
Why?
|
| Vitronectin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Benzene Derivatives | 1 | 2006 | 7 | 0.020 |
Why?
|
| Butadienes | 1 | 2006 | 33 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 2001 | 370 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2006 | 24 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2006 | 22 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2006 | 8 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2006 | 52 | 0.020 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2006 | 11 | 0.020 |
Why?
|
| Molecular Weight | 3 | 1992 | 332 | 0.020 |
Why?
|
| Glutathione Transferase | 2 | 1996 | 111 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 121 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 21 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 143 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 115 | 0.020 |
Why?
|
| Diacetyl | 1 | 2005 | 5 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2005 | 13 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 28 | 0.020 |
Why?
|
| Thiazolidines | 1 | 2005 | 17 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2005 | 55 | 0.020 |
Why?
|
| Azepines | 1 | 2005 | 20 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2005 | 87 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2006 | 164 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 1996 | 94 | 0.020 |
Why?
|
| Ion Channels | 1 | 1987 | 246 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2005 | 45 | 0.020 |
Why?
|
| Protein Folding | 1 | 2007 | 280 | 0.020 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1985 | 7 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 8475 | 0.020 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2005 | 22 | 0.020 |
Why?
|
| Fetus | 1 | 2006 | 226 | 0.020 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2005 | 76 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 2005 | 15 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 181 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 86 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2005 | 37 | 0.020 |
Why?
|
| Poly I-C | 1 | 1985 | 16 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 912 | 0.020 |
Why?
|
| Nerve Net | 1 | 2009 | 366 | 0.020 |
Why?
|
| Dicarboxylic Acid Transporters | 1 | 2004 | 2 | 0.020 |
Why?
|
| Thiazoles | 1 | 2005 | 131 | 0.020 |
Why?
|
| Phenylalanine | 1 | 1984 | 37 | 0.020 |
Why?
|
| Streptozocin | 1 | 2004 | 54 | 0.020 |
Why?
|
| Thymine | 1 | 2004 | 17 | 0.020 |
Why?
|
| Epidermis | 1 | 2005 | 100 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2004 | 37 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2004 | 69 | 0.020 |
Why?
|
| Enterovirus Infections | 1 | 1984 | 41 | 0.020 |
Why?
|
| Carboxy-Lyases | 1 | 2004 | 22 | 0.020 |
Why?
|
| Sulfones | 1 | 2004 | 43 | 0.020 |
Why?
|
| Staurosporine | 1 | 2004 | 33 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 1996 | 15 | 0.020 |
Why?
|
| Benzazepines | 1 | 2004 | 89 | 0.020 |
Why?
|
| Clone Cells | 1 | 2004 | 213 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 144 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2003 | 7 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2005 | 192 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2003 | 32 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2003 | 35 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2004 | 140 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 388 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 23 | 0.010 |
Why?
|
| Ceramides | 1 | 2003 | 35 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 223 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2003 | 130 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2003 | 19 | 0.010 |
Why?
|
| Doxycycline | 1 | 2003 | 27 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2003 | 92 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2003 | 88 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 54 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 196 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 251 | 0.010 |
Why?
|
| Oxygen Radioisotopes | 1 | 2002 | 4 | 0.010 |
Why?
|
| Artifacts | 1 | 2004 | 244 | 0.010 |
Why?
|
| Perfusion | 1 | 2003 | 203 | 0.010 |
Why?
|
| Hyperemia | 1 | 2002 | 19 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 92 | 0.010 |
Why?
|
| Dendrimers | 1 | 2002 | 11 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 102 | 0.010 |
Why?
|
| DNA Repair | 1 | 2004 | 356 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 101 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2002 | 123 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 270 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 119 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 104 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2002 | 124 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 286 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 280 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2002 | 81 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2004 | 370 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2001 | 78 | 0.010 |
Why?
|
| Jagged-1 Protein | 1 | 2001 | 11 | 0.010 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2001 | 12 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 1241 | 0.010 |
Why?
|
| Epithelium | 1 | 2002 | 319 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2001 | 135 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2001 | 44 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1971 | 103 | 0.010 |
Why?
|
| Swine | 1 | 2002 | 555 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 2001 | 43 | 0.010 |
Why?
|
| Pericytes | 1 | 2000 | 12 | 0.010 |
Why?
|
| Protein Kinase C-delta | 1 | 2000 | 26 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 2000 | 27 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 1197 | 0.010 |
Why?
|
| Synaptotagmins | 1 | 2000 | 7 | 0.010 |
Why?
|
| Synaptotagmin I | 1 | 2000 | 16 | 0.010 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 1999 | 5 | 0.010 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 1999 | 5 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1999 | 6 | 0.010 |
Why?
|
| Son of Sevenless Protein, Drosophila | 1 | 1999 | 2 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2000 | 39 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 179 | 0.010 |
Why?
|
| Capillaries | 1 | 2000 | 91 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2000 | 88 | 0.010 |
Why?
|
| Gene Frequency | 2 | 1991 | 677 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 57 | 0.010 |
Why?
|
| Triglycerides | 1 | 2000 | 232 | 0.010 |
Why?
|
| Chromogranin A | 2 | 1989 | 8 | 0.010 |
Why?
|
| Chromogranins | 2 | 1989 | 11 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 157 | 0.010 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1998 | 5 | 0.010 |
Why?
|
| Luminescence | 1 | 1998 | 16 | 0.010 |
Why?
|
| Coleoptera | 1 | 1998 | 13 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1999 | 181 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1998 | 18 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 164 | 0.010 |
Why?
|
| Retroelements | 1 | 1998 | 44 | 0.010 |
Why?
|
| Antibodies | 1 | 2000 | 350 | 0.010 |
Why?
|
| Imidazoles | 1 | 1999 | 162 | 0.010 |
Why?
|
| Mouthwashes | 1 | 1997 | 5 | 0.010 |
Why?
|
| Absorption | 1 | 1997 | 25 | 0.010 |
Why?
|
| Vesicle-Associated Membrane Protein 3 | 1 | 1996 | 1 | 0.010 |
Why?
|
| R-SNARE Proteins | 1 | 1996 | 5 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 1996 | 17 | 0.010 |
Why?
|
| Calcium Channels | 1 | 1998 | 182 | 0.010 |
Why?
|
| Qa-SNARE Proteins | 1 | 1996 | 17 | 0.010 |
Why?
|
| SNARE Proteins | 1 | 1996 | 26 | 0.010 |
Why?
|
| Botulinum Toxins | 1 | 1996 | 17 | 0.010 |
Why?
|
| Organelles | 1 | 1996 | 52 | 0.010 |
Why?
|
| Glipizide | 1 | 1996 | 2 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1996 | 117 | 0.010 |
Why?
|
| Uridine Diphosphate | 1 | 1996 | 5 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1996 | 19 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 1204 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1997 | 239 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 177 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1999 | 1056 | 0.010 |
Why?
|
| Furin | 1 | 1993 | 11 | 0.010 |
Why?
|
| Lamins | 1 | 1992 | 6 | 0.010 |
Why?
|
| Intermediate Filaments | 1 | 1992 | 16 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1992 | 27 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1992 | 107 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1992 | 117 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 30 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 416 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 126 | 0.010 |
Why?
|
| Chromatography | 1 | 1971 | 28 | 0.010 |
Why?
|
| Acrylates | 1 | 1971 | 19 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1971 | 55 | 0.010 |
Why?
|
| Esterases | 1 | 1971 | 12 | 0.010 |
Why?
|
| Gels | 1 | 1971 | 48 | 0.010 |
Why?
|
| Acetates | 1 | 1971 | 66 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1992 | 623 | 0.010 |
Why?
|
| Species Specificity | 1 | 1992 | 678 | 0.010 |
Why?
|
| Pedigree | 1 | 1992 | 966 | 0.010 |
Why?
|
| Mannoheptulose | 1 | 1989 | 2 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 1989 | 8 | 0.010 |
Why?
|
| Database Management Systems | 1 | 1990 | 41 | 0.010 |
Why?
|
| Endothelins | 1 | 1989 | 35 | 0.010 |
Why?
|
| Quality Control | 1 | 1990 | 117 | 0.010 |
Why?
|
| Xenopus | 1 | 1989 | 125 | 0.010 |
Why?
|
| Glutamine | 1 | 1989 | 76 | 0.010 |
Why?
|
| Receptors, Laminin | 1 | 1989 | 6 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 1989 | 66 | 0.010 |
Why?
|
| Oocytes | 1 | 1989 | 221 | 0.010 |
Why?
|
| Methionine | 1 | 1989 | 66 | 0.010 |
Why?
|
| Dogs | 1 | 1989 | 685 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1989 | 303 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1989 | 177 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1992 | 696 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1986 | 24 | 0.000 |
Why?
|
| Encephalomyocarditis virus | 1 | 1984 | 40 | 0.000 |
Why?
|